CDKN2A and cancer: p16 methylation was also associated with palbociclib sensitivity in an vitro survey of cell lines from various cancers and increasing p16 methylation in lung and gastric cancer cell lines by transfection with a DNA methyltransferase increased their palbociclib sensitivity [24].